» Articles » PMID: 37054905

Epigenetic Programing of Cancer Stemness by Transcription Factors-non-coding RNAs Interactions

Overview
Specialty Oncology
Date 2023 Apr 13
PMID 37054905
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer 'stemness' is fundamental to cancer existence. It defines the ability of cancer cells to indefinitely perpetuate as well as differentiate. Cancer stem cell populations within a growing tumor also help evade the inhibitory effects of chemo- as well as radiation-therapies, in addition to playing an important role in cancer metastases. NF-κB and STAT-3 are representative transcription factors (TFs) that have long been associated with cancer stemness, thus presenting as attractive targets for cancer therapy. The growing interest in non-coding RNAs (ncRNAs) in the recent years has provided further insight into the mechanisms by which TFs influence cancer stem cell characteristics. There is evidence for a direct regulation of TFs by ncRNAs, such as, microRNAs (miRNAs), long non-coding RNAs (lncRNAs) as well as circular RNAs (circRNAs), and vice versa. Additionally, the TF-ncRNAs regulations are often indirect, involving ncRNA-target genes or the sponging of other ncRNA species by individual ncRNAs. The information is rapidly evolving and this review provides a comprehensive review of TF-ncRNAs interactions with implications on cancer stemness and in response to therapies. Such knowledge will help uncover the many levels of tight regulations that control cancer stemness, providing novel opportunities and targets for therapy in the process.

Citing Articles

MLLT3 Regulates Melanoma Stemness and Progression by Inhibiting HMGB1 Nuclear Entry and MAGEA1 MC Modification.

Li Y, Liu H, Li J, Fu C, Jiang B, Chen B Adv Sci (Weinh). 2024; 12(10):e2408529.

PMID: 39716999 PMC: 11904942. DOI: 10.1002/advs.202408529.


Inhibition of miR-4763-3p expression activates the PI3K/mTOR/Bcl2 autophagy signaling pathway to ameliorate cognitive decline.

Qi W, Ying Y, Wu P, Dong N, Fu W, Liu Q Int J Biol Sci. 2024; 20(15):5999-6017.

PMID: 39664587 PMC: 11628338. DOI: 10.7150/ijbs.103225.


Glucose metabolism in glioma: an emerging sight with ncRNAs.

Rong J, Wang Q, Li T, Qian J, Cheng J Cancer Cell Int. 2024; 24(1):316.

PMID: 39272133 PMC: 11395608. DOI: 10.1186/s12935-024-03499-8.


Roles and mechanisms of circular RNA in respiratory system cancers.

Yang N, Jiao M, Zhang Y, Mo S, Wang L, Liang J Front Oncol. 2024; 14:1430051.

PMID: 39077467 PMC: 11284073. DOI: 10.3389/fonc.2024.1430051.


New mechanism of LncRNA: In addition to act as a ceRNA.

Zhang J, Zhu H, Li L, Gao Y, Yu B, Ma G Noncoding RNA Res. 2024; 9(4):1050-1060.

PMID: 39022688 PMC: 11254507. DOI: 10.1016/j.ncrna.2024.06.002.